Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;4(1):88-90.
doi: 10.1016/j.ijscr.2012.09.009. Epub 2012 Oct 5.

Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder

Anthony Roylance  1 , John Mosley, Mohideen Jameel, Axel Sylvan, Virginie Walker
Affiliations

Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder

Anthony Roylance et al. Int J Surg Case Rep. 2013.

Abstract

Introduction: Intravesical BCG-instillation for bladder cancer is considered safe but is not without risk. While most side-effects are localised and self-limiting, the development of secondary vascular pathology is a rare but significant complication.

Presentation of case: A 77-year-old male presented with a mycotic abdominal aortic aneurysm and associated aorto-enteric fistula 18 months after receiving intravesical BCG-instillations for early stage transitional cell carcinoma.

Discussion: Response rates to intravesical BCG for early stage transitional cell carcinoma are high. The procedure produces a localised inflammatory response in the bladder but the exact mechanism of action is unclear. The treatment is generally well tolerated but BCG-sepsis and secondary vascular complications have been documented. Mycotic abdominal aortic aneurysm with associated aorto-enteric fistula secondary to BCG is very rare. Few examples have been documented internationally and the extent of corresponding research and associated management proposals is limited. Surgical options include in situ repair with prosthetic graft, debridement with extra-anatomical bypass and, occasionally, endovascular stent grafting. Recommended medical therapy for systemic BCG infection is Isoniazid, Rifampicin and Ethambutol.

Conclusion: Current screening methods must be updated with clarification regarding duration of anti-tuberculous therapy and impact of concomitant anti-tuberculous medication on the therapeutic action of intravesical BCG. Long-term outcomes for patients post graft repair for mycotic aneurysm are unknown and more research is required regarding the susceptibility of vascular grafts to mycobacterial infection. Recognition of the risks associated with BCG-instillations, even in immunocompetent subjects, is paramount and must be considered even several months or years after receiving the therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Abdominal CT with aortic aneurysm protocol demonstrating haematoma into the right psoas muscle (i) and a potential aorto-duodenal communication (ii).
Fig. 2
Fig. 2
Three-dimensional (3D) representation of the abdominal aortic aneurysm, illustrating its lobulated appearance.
See this image and copyright information in PMC

References

    1. Alexandroff A.B., Jackson A.M., O’Donnell M.A., James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999;353(9165):1689–1694. - PubMed
    1. Kemp T.J., Ludwig A.T., Earel J.K., Moore J.M., van Oosten R.L., Moses B. Neutrophil stimulation with Mycobacterium bovis bacillus Calmette–Guérin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Journal of the American Society of Haematology. 2005;106(10):3474–3482. - PMC - PubMed
    1. Harding G.E.J., Lawler D.K. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette–Guérin. Journal of Vascular Surgery. 2007;46(1):131–134. - PubMed
    1. Coscas R., Arlet J.-B., Belhomme D., Fabiani J.-N., Pouchot J. Multiple mycotic aneurysms due to Mycobacterium bovis after intravesical bacillus Calmette–Guérin therapy. Journal of Vascular Surgery. 2009;50(5):1185–1190. - PubMed
    1. Gao C.Q., Mithani R., Leya J., Dawravoo L., Bhatia A., Antoine J. Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical bacillus Calmette–Guérin therapy: case report. BMC Infectious Diseases. 2011;11:260. - PMC - PubMed